Literature DB >> 26979650

Outcomes of Adolescent-Onset Postural Orthostatic Tachycardia Syndrome.

Roma Bhatia1, Sarah J Kizilbash2, Shelley P Ahrens2, Jill M Killian3, Stephanie A Kimmes2, Erin E Knoebel2, Prasuna Muppa2, Amy L Weaver3, Philip R Fischer4.   

Abstract

OBJECTIVES: To determine the clinical course of adolescent-onset postural orthostatic tachycardia syndrome (POTS) and to assess health-related quality of life, 2-10 years after diagnosis. STUDY
DESIGN: Pediatric patients, 13-18 years of age, diagnosed with POTS at Mayo Clinic, Rochester, from 2003 to 2010 were mailed a questionnaire if they were at least 18 years of age at the time of the mailing. The primary outcome measures were norm-based, age- and sex-adjusted, 36-Item Short Form Health Survey physical composite score and mental composite score.
RESULTS: The survey was mailed to 502 patients with a response rate of 34% (n = 172). The mean duration from diagnosis to survey completion was 5.4 (SD, 1.9) years; the mean age of the respondents at the time of the survey was 21.8 (2.2) years. The responders were predominantly females (84% vs 68% of nonresponders; P < .001). Only 33 (19%) respondents reported complete resolution of symptoms, and an additional 51% reported persistent but improved symptoms, and 28 (16%) had only intermittent symptoms. The majority (71%) consider their health at least "good." The mean physical composite score was significantly lower than the population norm (mean [SD], 36.6 [15.8] vs 50; P < .001), however, the corresponding mean mental composite score was normal (50.1 [11.2]).
CONCLUSIONS: Overall, 86% of adolescents with POTS report resolved, improved, or just intermittent symptoms, when assessed via questionnaire at an average of 5 years after initial treatment. Patients with persistent symptoms have more physical than mental health concerns.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  autonomic dysfunction; chronic fatigue; dizziness; dysautonomia

Mesh:

Year:  2016        PMID: 26979650     DOI: 10.1016/j.jpeds.2016.02.035

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management.

Authors:  Adena Zadourian; Taylor A Doherty; Iwona Swiatkiewicz; Pam R Taub
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 2.  Postural Orthostatic Tachycardia Syndrome.

Authors:  Payam Safavi-Naeini; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2020-02-01

Review 3.  Postural tachycardia syndrome - Diagnosis, physiology, and prognosis.

Authors:  Amy C Arnold; Jessica Ng; Satish R Raj
Journal:  Auton Neurosci       Date:  2018-02-28       Impact factor: 3.145

Review 4.  Pediatric Disorders of Orthostatic Intolerance.

Authors:  Julian M Stewart; Jeffrey R Boris; Gisela Chelimsky; Phillip R Fischer; John E Fortunato; Blair P Grubb; Geoffrey L Heyer; Imad T Jarjour; Marvin S Medow; Mohammed T Numan; Paolo T Pianosi; Wolfgang Singer; Sally Tarbell; Thomas C Chelimsky
Journal:  Pediatrics       Date:  2017-12-08       Impact factor: 7.124

5.  Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Authors:  Jangsup Moon; Do-Yong Kim; Woo-Jin Lee; Han Sang Lee; Jung-Ah Lim; Tae-Joon Kim; Jin-Sun Jun; Byeongsu Park; Jung-Ick Byun; Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

6.  Health-related quality of life and suicide risk in postural tachycardia syndrome.

Authors:  Cathy L Pederson; Jill Blettner Brook
Journal:  Clin Auton Res       Date:  2017-02-06       Impact factor: 4.435

Review 7. 

Authors:  Satish R Raj; Artur Fedorowski; Robert S Sheldon
Journal:  CMAJ       Date:  2022-06-20       Impact factor: 16.859

Review 8.  Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?

Authors:  Svetlana Blitshteyn
Journal:  J Neurol       Date:  2021-03-07       Impact factor: 4.849

Review 9.  Postural tachycardia syndrome: current perspectives.

Authors:  Rachel Wells; Andrew J Spurrier; Dominik Linz; Celine Gallagher; Rajiv Mahajan; Prashanthan Sanders; Amanda Page; Dennis H Lau
Journal:  Vasc Health Risk Manag       Date:  2017-12-29

Review 10.  Activity and Exercise Intolerance After Concussion: Identification and Management of Postural Orthostatic Tachycardia Syndrome.

Authors:  Nicole A Miranda; Jeffrey R Boris; Kristen M Kouvel; Lauren Stiles
Journal:  J Neurol Phys Ther       Date:  2018-07       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.